Corindus’ CorPath GRX cleared for both PCI, peripheral vascular intervention

Daniel Allar | | Cardiovascular Business | Vascular & Endovascular

Already approved for robot-assisted PCI, Corindus Vascular Robotics’ CorPath GRX System is now cleared by the FDA for peripheral vascular interventions (PVIs). The system is the first to receive FDA clearance for both procedures.

According to Corindus, peripheral artery disease (PAD) affects an estimated 8.5 million people in the United States.

"My colleagues and I have seen first-hand how CorPath GRX can overcome the challenges of manual PCI and I am excited to apply the capabilities of robotics to effectively treat PAD patients," said Alan Lumsden, MD, chief of the department of cardiovascular surgery at Houston Methodist Hospital. "As a training site for future robotic interventionalists, I look forward to teaching these techniques to further enhance the quality of care for patients with both CAD and PAD."

Corindus is interested in exploring whether its technology can facilitate procedures performed by operators in remote locations, in addition to robot-assisted procedures. In January, the company announced it was partnering with Mayo Clinic to test the feasibility of “telestenting,” which could ultimately provide more access to PCI for rural and underserved populations.

""
Daniel Allar

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."